Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Argenta Discovery was a leading UK-based drug discovery company specializing in small molecule therapeutics, particularly in respiratory diseases. It provided integrated drug discovery services for pharma and biotech clients globally. Its own pipeline focused on novel therapies for serious respiratory conditions through Phase IIa proof-of-concept before partnering. The service division was acquired by Galapagos in February 2010; the internal respiratory pipeline became Pulmagen Therapeutics. The company is now dissolved as an independent entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Argenta Discovery.